Navigation Links
Researchers identify mechanism that could help old muscle grow
Date:6/17/2014

[Boston, MA June 17, 2014]─ Sarcopenia the significant loss of muscle mass and function that can occur as we age is associated with many chronic conditions such as diabetes, high cholesterol and obesity. In findings published online ahead of publication in the September 2014 issue of the FASEB Journal, researchers at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University identify a muscle-building mechanism that could be important in addressing sarcopenia.

When people strength train the body responds by making muscle. The researchers recruited 16 healthy but sedentary men to perform a single bout of resistance exercise to trigger muscle growth and examined tissue samples taken before and six hours after the exercise. Half of the men were in their twenties and the other half in their seventies.

"In order for the body to make proteins that build muscle, certain genes need to be turned on," said lead author Donato A. Rivas, Ph.D., a scientist in the Nutrition, Exercise Physiology and Sarcopenia Laboratory at the USDA HNRCA at Tufts University. "We noticed the older people had a lot fewer genes turned on compared to the younger people, showing us their muscles weren't responding as well to the exercise."

Rivas and colleagues observed that the level of microRNAs, small RNA molecules that have a prominent role in regulating genes, was lower in the muscle tissue of the older men, compared to younger men. "One of the steps in building muscle seems to be missing in the older men, preventing them from responding to the exercise as strongly as the younger men did," Rivas said. "It is possible that the suppression of these microRNAs is setting off a chain of events that is causing older people to be less efficient in developing muscle."

With the population of older adults in the United States projected to increase significantly in the coming decades, more effective sarcopenia treatment and prevention could help control healthcare costs. "Age-related muscle loss has been associated with a myriad of other health problems," said senior author Roger A. Fielding, Ph.D., director of the Nutrition, Exercise Physiology and Sarcopenia Laboratory at the USDA HNRCA at Tufts University. "Muscle mass is closely tied to our metabolism and losing it increases the risk of developing metabolic diseases like type 2 diabetes and cardiovascular disease. We also know that a program of moderate physical activity, including resistance exercises, can strongly influence a person's chances of maintaining their ability to walk after age 70."

In addition to resistance exercises, scientists are exploring different approaches to preserving and building muscle mass in older adults. "A few studies suggest gene therapy, nutrient supplementation or hormone replacement therapy can assist with building muscle," said Fielding, who is also a professor at the Friedman School of Nutrition Science and Policy at Tufts University and the Tufts University School of Medicine. "Our identification of a possible microRNA target could help advance the study of these largely untested, but promising approaches to promoting muscle growth in older people."

The authors note the small size of the study necessitates future research in clinical models and in men and women, particularly those who have sarcopenia.


'/>"/>

Contact: Andrea Grossman
617-636-3728
Tufts University, Health Sciences Campus
Source:Eurekalert

Related medicine news :

1. Researchers identify new compound to treat depression
2. Researchers create better methods to detect E. coli
3. UGA researchers discover new method to reduce disease-causing inflammation
4. Ottawa researchers key to new neuromuscular disease care and research network
5. Researchers uncover new insights into developing rapid-acting antidepressant for treatment-resistant depression
6. Broad Institute, MGH researchers chart cellular complexity of brain tumors
7. Researchers uncover common heart drugs link to diabetes
8. Mayo Clinic researchers discover new form of cancer
9. Researchers recast addiction as a manageable disease
10. Mount Sinai researchers identify protein that keeps blood stem cells healthy as they age
11. Berkeley Lab researchers create nanoparticle thin films that self-assemble in 1 minute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... 2017 , ... Miro is the ultimate smart media center that offers a ... TV shows and much more apps for user exploration. Its innovative acoustic design with ... 1280 x 720 provides crisp images with remarkable clarity and color. The WiFi connection ...
(Date:2/27/2017)... ... 27, 2017 , ... Sunshine Coast Health Centre (SCHC), one ... at https://www.sunshinecoasthealthcentre.ca/ , is proud to announce the addition of a registered ... Centre's commitment to innovation in drug rehab and alcohol treatment strategies beyond a ...
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... New Jersey ... rates, among all types and genders. And the need for advanced services is growing. ... and its top-rated cancer care program, in collaboration with their non-profit partners in their ...
(Date:2/26/2017)... ... February 26, 2017 , ... This is ... the world’s first to be ISO/IEC 17025:2005 INAB accredited for Der p 1 ... 17025:2005 is the globally recognised standard that sets out requirements for the technical ...
(Date:2/26/2017)... ... 2017 , ... IndustryArchive.Org . is announcing a new way for B2B ... now only pay for B.A.N.T. quality sales leads based on the Sellers decision to ... new reality that B2B buyers are controlling the sales process via the Internet and ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)... 27, 2017   Royal Philips (NYSE: ... leader in health technology, today announced 510(k) clearance ... to market its ElastQ Imaging capability, further expanding ... systems. ElastQ Imaging enables simultaneous imaging of tissue ... for the diagnosis of various liver conditions. With ...
(Date:2/27/2017)... , Feb. 27, 2017  RegeneRx Biopharmaceuticals, Inc. ... drug development company focused on tissue protection, repair ... RGN-137, GtreeBNT Co., Ltd., received a positive response ... clinical trial design for RGN-137 to treat epidermolysis ... gel that incorporates Thymosin beta 4 ("Tß4") as ...
(Date:2/27/2017)... BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) today announced ... President and Chief Executive Officer (CEO) and member of the ... Richard Love , interim President and CEO who will ... Craig has over 20 years of experience in hematology, oncology ... Europe . "On behalf of CTI BioPharma,s ...
Breaking Medicine Technology: